Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ritter

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pediatric Neurology|November 7, 2025
Limited Utility for Head Ultrasounds in the Evaluation of Tuberous Sclerosis ComplexSavannah Stultz, Darcy A Krueger, David N Franz, et al.
Pediatric Neurology|September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate TreatmentLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Pediatric Neurology|May 7, 2021
Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR InhibitorsKaren Agricola, Gabrielle Stires, Darcy A Krueger, et al.
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injuryDavid M Ritter, Benjamin M Zemel, Tamara J Hala, et al.
American Journal of Medical Genetics. Part A|July 3, 2025
Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma-Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis ComplexDavid M Ritter, Kristin Schneider, Nkiru Ezeakudo, et al.
Orphanet Journal of Rare Diseases|March 16, 2022
Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complexDavid M Ritter, Bailey K Fessler, Daniel Ebrahimi-Fakhari, et al.
NPJ Genomic Medicine|March 18, 2026
Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndromeLamis Yehia, Lin Li, Gideon Idumah, et al.
Eneuro|July 11, 2023
Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female MiceDurgesh Tiwari, Valerine Rajathi, Jeffrey K Rymer, et al.
Annals of Clinical and Translational Neurology|March 19, 2024
Exploring the neurological features of individuals with germline PTEN variants: A multicenter studyAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pediatric Neurology|November 7, 2025
Limited Utility for Head Ultrasounds in the Evaluation of Tuberous Sclerosis ComplexSavannah Stultz, Darcy A Krueger, David N Franz, et al.
Pediatric Neurology|September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate TreatmentLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Pediatric Neurology|May 7, 2021
Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR InhibitorsKaren Agricola, Gabrielle Stires, Darcy A Krueger, et al.
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injuryDavid M Ritter, Benjamin M Zemel, Tamara J Hala, et al.
American Journal of Medical Genetics. Part A|July 3, 2025
Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma-Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis ComplexDavid M Ritter, Kristin Schneider, Nkiru Ezeakudo, et al.
Orphanet Journal of Rare Diseases|March 16, 2022
Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complexDavid M Ritter, Bailey K Fessler, Daniel Ebrahimi-Fakhari, et al.
NPJ Genomic Medicine|March 18, 2026
Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndromeLamis Yehia, Lin Li, Gideon Idumah, et al.
Eneuro|July 11, 2023
Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female MiceDurgesh Tiwari, Valerine Rajathi, Jeffrey K Rymer, et al.
Annals of Clinical and Translational Neurology|March 19, 2024
Exploring the neurological features of individuals with germline PTEN variants: A multicenter studyAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Pageof 3